
NSCLC
metformin
AMP
non-small cell lung cancer
Akt
mTOR
LKB1
AMPK
p53
child
lung cancer
tumor
cancer
Metformin
diabetic
malignancy
Non-small cell lung cancer
patients
stage tumors
RTOG-0617
Platinum
deaths
Non-Small Cell Lung Cancer
squamous cell carcinomas
adenocarcinomas
cell carcinomas
Epidermal Growth Factor Receptor
EGFR
K-Ras
TP53
Liver Kinase B 1
lung cancers
RTOG 0324
Raf
Mek
Erk
mammalian Target of Rapamycin
TSC2
Rheb
PRAS40
mTORC1
mLST8
p70S6-kinase
p70s6k
eIF4E binding protein 1
4EBP1
Sterol Regulatory Element-Binding Proteins (SREBP) 1a
c and 2
ACLY
ACC1
FASN
SREBP1a and 1c
SREBP2
Raptor
MRE11
ATM
histone H2Ax
p21cip1
ATM-AMPK
cholesterol
fatty acid
tumors
Tuberous Sclerosis Complex
Phosphatidyl-inositol
Tuberous Sclerosis Complex 2
glucose
mammalian
xenografts
pneumonitis
Phosphatidylinositol
Lung adenocarcinomas
ATR
Chk1
Chk2
Cdk2
Cdk1
Ataxia Telengiectasia
solid tumors
F18-FDG
Hypoxia of the tumor
2-deoxy-D-glucose
18F
oxygen
Glucose transport and glycolysis
GLUT1
glucose-6-phosphate
Glucose metabolism
ATP Citrate Lyase
fatty acid synthase
HMG-CoA reductase
HMGR
malonyl-CoA
ATP
HMG-CoA
acetoacetyl-CoA
tricarboxylate
geranyl-PP diphosphates
acetyl-CoA
TCA
pyruvate
isoprenoids
palmitic acid
Acetyl-CoA
pentose phosphate
Malonyl-CoA
ribose 5-phosphate
farnesyl-PP
ADP
Cholesterol
Acetyl CoA
Glucose
mevalonate
citrate
Fatty acid synthase
HMG-CoA Reductase
glutamine
statins
Citrate
mouse
colon cancer
aggressive tumors
lung and colon cancer
lovastatin
Lkb1
lung adenocarcinomas
hamartomas
Peutz-Jeghers syndrome
lung cancer carcinogenesis
polyps
adenomatous hyperplasia
invasive disease
(beta1
beta2
cystathionine beta synthase
AMPK beta1
yeast
C. Elegans
Human
humans
salicylate
hypoxia
A-769662
threonine
carbohydrate
Ser
insulin
Insulin-like growth factor I
Insulin Receptor Substrate (IRS)-1
B-RAF
MEK
ERK
BRAF
Kinase Suppressor of Ras (KSR) 1
IGF-1
TSC1
p70-S6 kinase
p70S6K
eukaryotic initiation factor 4E
eIF4E) binding protein 1
Thr1227
Tuberous Sclerosis 2
ACC2
obese
Ser212
alanine
sterol
p27kip1
mitosis
glucose deprivation
HIF1alpha
FOXO3a
SREBP1c
Bcl-2
caspase 6
vascular endothelial growth factor
VEGF
O3
hepatic glucose output
glucose metabolism
hepatic gluconeogenesis
AMPKalpha1
sestrin 2
mice
human
MEFs
A549
cytotoxicity in NSCLC
toxicity
diabetics
METFORMIN
buformin
1-(diaminomethylidene)-3,3-dimethyl-guanidine
biguanide
non-alcoholic liver disease
guanidine
phenoformin
galega officinalis
galegine
biguanides
lactic acidosis
polycystic ovary syndrome
small cell lung cancer
phenformin
Oxygen
LLC1
Caveolin-1
Adenoviral
CALU-1
CALU-6
CALU-3
GLC82
Cisplotin
H460
H838
Paclitaxel
PC9
gefitinib
cisplatin
Cisplatin
Al
Phenformin
Gefitinib
Ashinuma etal
lung tumorigenesis
NNK
IP Gefitnib Cisplatin
Doxorubicin Carboplatin Paclitaxel
LKB-1
adenovirus
Adenocarcinoma
adenocarcinoma lines
SK-MES
N
squamous cell carcinoma
IGF-I
epidermoid cancer
breast cancer
etoposide
acidosis
Hypoxia induced factor (HIF)1
NDI1
HIF1a
Saccharomyces cerevisiae
hypoxic tumor
NADH
rapamycin
doxorubicin
paclitaxel
cytotoxicity
irradiated lung cancer
KU60019
HCT116
H1299 lung adenocarcinoma
lung tumors
colon carcinoma
Diabetic
glycemia
IN CANCER
sulfonylureas
diabetes
Lung cancer
patient
prostate cancer
type II diabetic
thiazolidenediones
adenocarcinoma
cisplatin-etoposide
diabetic and non-diabetic
Patients
male
III disease
type II diabetes
www.ClinicalTrials.govOctober 2016
Oct
Weight Loss
IL6
IGF1
IGFBP3
Women
p70S6k
Non Small Cell Lung Cancer
carboplatin
METRO
Adeno-carcinoma of lung
platinum
Carbohydrate
Non-small Cell Lung Cancer
toxicity Active NOT Recruiting NSCLC Locally Advanced NSCLC
Recruiting NSCLC
Carboplatin
Non-squamous Non-small Cell Lung Cancer
Toxicity
NCT01717482
RTOG-GOG
carboplatin-paclitaxel
OCOG
MD Anderson Cancer
temsirolimus
IGF binding protein 3
weight loss
NCT02145559
sirolimus
cell lung cancer
Non-Small-Cell Lung Cancer
non-small-cell lung cancer
oat
carcinoma of the lung
non-small-cell lung carcinoma
vindesine
mitomycin
RTOG 0617
small-cell lung cancer
epidermal growth factor receptor
AKT
head and neck cancer
mammalian target of rapamycin
K-RAS
Everolimus
pulmonary toxicity
Insulin-Like Growth Factor-1 Receptor
Mammalian
Mammalian Target of Rapamycin
CHK1
CHK2
p21
GLUT-1
laryngeal carcinoma
apigenin
serine
PKB
Statins
ATP citrate lyase
colorectal cancer
ATP-citrate lyase
cancer metabolism
phosphatidylinositol
orlistat
metastasis of orthotopic tongue oral squamous cell carcinomas
KRAS
lung carcinoma
AMP-activated protein kinase
homocystinuria disease
Health and Disease
KSR1
raptor
TSC
Insulin
Atherosclerosis
Hepatic Steatosis
acetyl
Acc1
Acc2
p27
kip1
phospho-AMPKalphaThr172
mitosis and cytokinesis
myeloma cells
adenosine monophosphate
gastric cancer
Adenosine
atherosclerosis
hepatic steatosis
DU145
FOXO3
Sestrin2
Breast Cancer Cells
Kras
liver kinase B-1
lung adenocarcinoma
Etoposide
ECa109
ataxia telangiectasia mutated
MCF-7 breast cancer
HIF-1
tumor glucose metabolism
HER2
HIF-1alpha
hepatocellular carcinoma
metastases in prostate cancer
tyrosine
prostate and lung cancer
Salicylate
prolonging tumor
cyclin D1
endometrial cancer
renal insufficiency
Mouse
people
type 2 diabetes
thiazolidinedione
nonsmall cell lung cancer
Thiazolidinedione
esophageal adenocarcinoma
neck cancer treatment failure
carcinoma growth
tobacco
SREBP-1
